Phase I Targeted Combination Trial of Sorafenib and GW5074 in Patients with Advanced Refractory Solid Tumors.
Kao CC, Ho CL, Yang MH, Tsai YT, Liu SY, Chang PY, Wu YY, Chen JH, Huang TC, Yehn RH, Dai MS, Chen YC, Sun GH, Cha TL.
Kao CC, et al. Among authors: cha tl.
J Clin Med. 2022 Apr 14;11(8):2183. doi: 10.3390/jcm11082183.
J Clin Med. 2022.
PMID: 35456276
Free PMC article.